Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreNEW YORK - September 17, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCYSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCYNEW YORK - September 16, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCYSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCYNEW YORK - September 15, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unicycive (
NASDAQ:UNCY), Nutex Health Inc. (
NASDAQ:NUTX), LifeMD, Inc. (
NASDAQ:LFMD), and Snap, Inc. (
NYSE:SNAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCYNEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (
NASDAQ: UNCY) and certain officers. The class action, filed in the United States District Court Northern District of California, and docketed under 25-cv-06923, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Unicycive securities between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) ShareholdersSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) ShareholdersNEW YORK - September 12, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”). Unicycive is a clinical-stage biotechnology company.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK - September 11, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unicycive (
NASDAQ:UNCY), Nutex Health Inc. (
NASDAQ:NUTX), LifeMD, Inc. (
NASDAQ:LFMD), and Snap, Inc. (
NYSE:SNAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCYNEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (
NASDAQ: UNCY) and certain officers. The class action, filed in the United States District Court Northern District of California, and docketed under 25-cv-06923, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Unicycive securities between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK - September 10, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming DeadlineSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming DeadlineNEW YORK - September 9, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unicycive (
NASDAQ:UNCY), Nutex Health Inc. (
NASDAQ:NUTX), LifeMD, Inc. (
NASDAQ:LFMD), and Snap, Inc. (
NYSE:SNAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
